Drug recall · September 23, 2026
Thyroid Tablets recall
Why: Superpotent Drug
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
Thyroid Tablets, USP, 1/2 Grain (30 mg), Each tablet contains: levothyroxine (T4) 19 mcg, liothyronine (T3) 4.5 mcg, 100 Tablets, Rx only, Distributed by: Vitruvias Therapeutics, Auburn, AL 36830, Product of USA, NDC 69680-166-00.
- Lots / codes
Lot # 504950, Exp Date: 09/30/2026.
- Quantity
- 1955 bottles
- Company
- Vitruvias Therapeutics Inc, Auburn, AL
- Distribution
- US Nationwide.
- Initiated
- August 21, 2026 · Voluntary: Firm initiated
- Classified
- September 22, 2026
- Reported
- September 23, 2026
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Thyroid (USP)
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.